Generic drugs should be cheap, but insurers are charging thousands of dollars for them

By The Wall Street Journal
| September 11, 2023

Health insurers mark up prices of generics for cancer, multiple sclerosis and other complicated diseases.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...